Exosome Diagnostic and Therapeutic Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Exosome Diagnostic and Therapeutic Market was valued at $39 million and is expected to reach $368 million by 2027, supported by a CAGR of 37% from 2021-2027.

Exosomes are defined as small membrane pockets/vesicles with a diameter of 30 to 100 nanometers (nm). They are extravascular vesicles of endosome origin. These are miRNA and mRNA bodies secreted by the cells of the blood, saliva, and body fluids of the amniotic fluid. Exosomes have properties such as regeneration and stability. These properties have made exosomes available for therapeutic purposes in gene and drug delivery. Exosomes play an important role in facilitating cell-to-cell communication in cancer prognosis. It induces apoptosis of activated cytotoxic T cells, suppressing immune function, enabling tumor progression in the human body. Also, exosomes stimulate angiogenesis and migration, leading to metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through the tumor necrosis factor pathway. In addition, medical professionals use exosomes to diagnose cancer to profile genetic changes in tumors and prevent the spread of the disease. It reduces the body’s immune function by stimulating the programmed apoptosis of activated cytotoxic T cells that modify neoplastic progression within the body.

Market Segments

By Product

• Instrument
• Reagent
• Software

By Application

• Diagnostic
• Therapeutic

By End-User

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

Key Players

Some of the key industry players include AMS Biotechnology Limited, 101BIO Therapeutic Solutions International, BioRegenerative Sciences, Cell Guidance Systems, ExoCyte Therapeutics, Evomic Science, Exosomedx, Immune Therapy, Norgen Biotek, ReNeuron Group and Thermofisher.

Scope of the Report

The research study analyzes the global Exosome Diagnostic and Therapeutic industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Exosome Diagnostic and Therapeutic Market Report

1. What was the Exosome Diagnostic and Therapeutic Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Exosome Diagnostic and Therapeutic Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Exosome Diagnostic and Therapeutic Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.